PT1891939E - Composições contendo compostos de amónio quaternário - Google Patents

Composições contendo compostos de amónio quaternário

Info

Publication number
PT1891939E
PT1891939E PT62912365T PT06291236T PT1891939E PT 1891939 E PT1891939 E PT 1891939E PT 62912365 T PT62912365 T PT 62912365T PT 06291236 T PT06291236 T PT 06291236T PT 1891939 E PT1891939 E PT 1891939E
Authority
PT
Portugal
Prior art keywords
weight
quaternary ammonium
compositions containing
ammonium compounds
containing quaternary
Prior art date
Application number
PT62912365T
Other languages
English (en)
Portuguese (pt)
Inventor
Betty Philips
Laura Rabinovich-Guilatt
Gregory Lambert
Frederic Lallemand
Original Assignee
Novagali Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37964164&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1891939(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novagali Pharma Sa filed Critical Novagali Pharma Sa
Publication of PT1891939E publication Critical patent/PT1891939E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A61K8/416—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/14—Preparations for removing make-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Birds (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT62912365T 2006-07-28 2006-07-28 Composições contendo compostos de amónio quaternário PT1891939E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06291236.5A EP1891939B1 (en) 2006-07-28 2006-07-28 Compositions containing quaternary ammonium compounds

Publications (1)

Publication Number Publication Date
PT1891939E true PT1891939E (pt) 2013-10-07

Family

ID=37964164

Family Applications (1)

Application Number Title Priority Date Filing Date
PT62912365T PT1891939E (pt) 2006-07-28 2006-07-28 Composições contendo compostos de amónio quaternário

Country Status (9)

Country Link
EP (1) EP1891939B1 (el)
CN (1) CN101534791B (el)
CY (1) CY1114457T1 (el)
DK (1) DK1891939T3 (el)
ES (1) ES2428868T3 (el)
HK (1) HK1112409A1 (el)
PL (1) PL1891939T3 (el)
PT (1) PT1891939E (el)
SI (1) SI1891939T1 (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2060262B1 (en) * 2007-11-14 2011-03-30 Novagali Pharma S.A. Composition comprising at least one nucleosidic moiety as a therapeutic agent, and ckc
WO2009063081A2 (en) * 2007-11-14 2009-05-22 Novagali Pharma Sa Composition comprising at least one nucleosidic moiety as a therapeutic agent, and ckc.
EP2077104A1 (en) * 2008-01-02 2009-07-08 Novagali Pharma SA Micellar compositions with ophtalmic applications
EP2077105A1 (en) * 2008-01-02 2009-07-08 Novagali Pharma SA Ophthalmic Micellar Compositions with Enhanced Stability
WO2018144909A1 (en) * 2017-02-03 2018-08-09 The Administrators Of The Tulane Educational Fund Ophthalmic compositions for therapeutic and prophylactic uses
CN113577024B (zh) * 2021-08-20 2023-05-05 山西利普达医药科技有限公司 一种眼用组合物及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB633175A (en) * 1946-09-03 1949-12-12 Parke Davis & Co Antibiotic preparations and process for obtaining the same
USB724600I5 (el) * 1968-04-26
US5951988A (en) * 1993-03-30 1999-09-14 University Of Saskatchewan Adjuvant formulation with enhanced immunogenic activity, and related compositions and methods
NO943200L (no) * 1993-08-30 1995-03-01 Curtis Helene Ind Inc Sjampokondisjoneringspreparat
US5547990A (en) * 1994-05-20 1996-08-20 Lonza, Inc. Disinfectants and sanitizers with reduced eye irritation potential
TW446563B (en) * 1996-01-16 2001-07-21 Colgate Palmolive Co Low static conditioning shampoo
US6071904A (en) * 1996-12-11 2000-06-06 Alcon Laboratories, Inc. Process for manufacturing ophthalmic suspensions
EP1115406A4 (en) * 1998-09-25 2003-03-05 Alcon Lab Inc SUSTAINABLE RELEASE OPHTHALMIC COMPOSITION AND METHOD OF EYE THERAPY
EP1929996B1 (en) * 2004-11-09 2011-02-16 Novagali Pharma S.A. Ophthalmic emulsions containing an immunosuppressive agent
ATE412400T1 (de) * 2004-11-09 2008-11-15 Novagali Pharma Sa Öl-in-wasser-emulsion mit niedriger konzentration des kationischen mittels und positivem zetapotential

Also Published As

Publication number Publication date
SI1891939T1 (sl) 2013-11-29
ES2428868T3 (es) 2013-11-12
CN101534791B (zh) 2012-01-11
CN101534791A (zh) 2009-09-16
EP1891939A1 (en) 2008-02-27
PL1891939T3 (pl) 2014-01-31
HK1112409A1 (en) 2008-09-05
DK1891939T3 (da) 2013-10-07
CY1114457T1 (el) 2016-10-05
EP1891939B1 (en) 2013-09-11

Similar Documents

Publication Publication Date Title
WO2008035246A3 (en) Compositions containing quaternary ammonium compounds
PT1891939E (pt) Composições contendo compostos de amónio quaternário
PT1984357E (pt) Compostos de 2,4-pirimidinadiamina para tratamento ou prevenção de doenças autoimunes
HK1107700A1 (en) Triazole compounds that modulate hsp90 activity
TW200738666A (en) Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
MX2008002061A (es) Derivados de tiazolil piperidina utiles como moduladores del receptor h3.
TW200700070A (en) Enhanced bimatoprost ophthalmic solution
HK1101178A1 (en) Alkynyl derivatives as modulators of metabotropic glutamate receptors
ATE483706T1 (de) Weitere heteropolycyclische verbindungen und deren verwendung als antagonisten des metabotropen glutamatrezeptors
MA31766B1 (fr) Composés organiques
DE602004029242D1 (en) Pyrazolamidverbindungen
DE602005010401D1 (de) Imidazolinderivate mit cb1-antagonistischer wirkung
GB0510143D0 (en) Novel compounds A1
TW200716519A (en) Benzoyl-substituted serineamides
HK1068136A1 (en) Muscarinic antagonists
UY28797A1 (es) 5,6-dialquil-7-amino-triazolopirimidinas, procedimientos para su preparación y el uso de las mismas para combatir hongos nocivos, así como productos que las contienen.
ATE467632T1 (de) Pyrroloä2,3-büpyridinderivate als modulatoren des h3-rezeptors
SI1765816T1 (sl) Substituirani 1-propiolil-piperazini z afiniteto za MGLUR5 receptor za zdravljenje bolečih stanj
EA200870060A1 (ru) Эмульсия бутилфталида для внутривенного введения и ее применение
DE602006010738D1 (de) Pyrroloä2,3-cüpyridinderivate
TW200724140A (en) Hydantoin compounds
NO20010486L (no) Betennelseshemmende tannpleiemidler
HK1154777A1 (en) Lipoprotein lipase-activating compositions comprising benzene derivatives
HK1147493A1 (en) 2-aminooxazole derivatives as trpvl antagonists useful for treating pain
ATE410203T1 (de) Lipase-hemmende zusammensetzung